Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Clinical Nuclear Medicine
|
January 24, 2023
177 Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177 Lu-PSMA-I&T
Ralph A Bundschuh, Christian H Pfob, Georgine Wienand, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2023
[<sup>99m</sup>Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
Matthias Konrad, Andreas Rinscheid, Georgine Wienand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 28, 2023
An Intrapatient Dosimetry Comparison of <sup>177</sup>Lu-rhPSMA-10.1 and <sup>177</sup>Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Andreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
EJNMMI Research
|
April 26, 2024
Biodistribution and radiation dosimetry of [<sup>99m</sup>Tc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
Andreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 9, 2023
Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer
Thomas Günther, Nadine Holzleitner, Oliver Viering, et al.
Circulation. Cardiovascular Imaging
|
November 13, 2024
[<sup>99m</sup>Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction
Alessandro Liebich, Ralph A Bundschuh, Christian H Pfob, et al.
Clinical Nuclear Medicine
|
August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid Cancer
Oliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma
Oliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
Alexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Clinical Nuclear Medicine
|
January 24, 2023
177 Lu-rhPSMA-10.1 Induces Tumor Response in a Patient With mCRPC After PSMA-Directed Radioligand Therapy With 177 Lu-PSMA-I&T
Ralph A Bundschuh, Christian H Pfob, Georgine Wienand, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 19, 2023
[<sup>99m</sup>Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience
Matthias Konrad, Andreas Rinscheid, Georgine Wienand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 28, 2023
An Intrapatient Dosimetry Comparison of <sup>177</sup>Lu-rhPSMA-10.1 and <sup>177</sup>Lu-PSMA-I&T in Patients with Metastatic Castration-Resistant Prostate Cancer
Andreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
EJNMMI Research
|
April 26, 2024
Biodistribution and radiation dosimetry of [<sup>99m</sup>Tc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer
Andreas Rinscheid, Alexander Gäble, Georgine Wienand, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 9, 2023
Preclinical Evaluation of Minigastrin Analogs and Proof-of-Concept [<sup>68</sup>Ga]Ga-DOTA-CCK-66 PET/CT in 2 Patients with Medullary Thyroid Cancer
Thomas Günther, Nadine Holzleitner, Oliver Viering, et al.
Circulation. Cardiovascular Imaging
|
November 13, 2024
[<sup>99m</sup>Tc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction
Alessandro Liebich, Ralph A Bundschuh, Christian H Pfob, et al.
Clinical Nuclear Medicine
|
August 2, 2024
Biodistribution and Radiation Dosimetry for 68 Ga-DOTA-CCK-66, a Novel CCK 2 R-Targeting Compound for Imaging of Medullary Thyroid Cancer
Oliver Viering, Andreas Rinscheid, Nadine Holzleitner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 25, 2025
Biodistribution and Radiation Dosimetry of [<sup>68</sup>Ga]Ga-RAYZ-8009, a Glypican 3-Targeting Compound for Imaging of Hepatocellular Carcinoma
Oliver Viering, Julia Brosch-Lenz, Ralph A Bundschuh, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
First Safety and Efficacy Data with the Radiohybrid <sup>177</sup>Lu-rhPSMA-10.1 for the Treatment of Metastatic Prostate Cancer
Alexander Dierks, Alexander Gäble, Andreas Rinscheid, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 5, 2024
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [<sup>99m</sup>Tc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Johanna S Enke, Kathrin Ritzel, Evelyn Asbach, et al.
Page
of 2